Key Points
-
Global downregulation of microRNA (miRNA) expression is an apparent feature of many tumours. Oncogenic or tumour-suppressive functions have been assigned to numerous miRNAs.
-
Alterations in key players of miRNA biogenesis affect mature miRNA levels in a global manner, whereas RNA-binding proteins (RBPs) regulating specific miRNAs can contribute to differences in the production of specific (subsets of) miRNAs.
-
The observation that miRNA binding to target mRNAs can repress gene expression through distinct mechanisms suggests the involvement of accessory proteins, some of which are linked to cancer.
-
Interplay between miRNAs and RBPs on target 3′ untranslated regions can rapidly modulate target expression under specific conditions. Binding of RBPs near miRNA target sites can potentially regulate miRNA function either directly by affecting miRNA binding or indirectly through a switch in RNA secondary structure.
-
The activity of RBPs is temporally and spatially regulated through changes in transcription rate, post-translational modifications and subcellular localization, and is sometimes deregulated in cancer and other diseases.
-
The data discussed in this Review illustrate several examples of mechanisms for miRNA–RBP interplay that could hold true for other miRNAs and RBPs. As some of these mechanisms are linked to oncogenesis, the challenge now is to connect the mechanisms of action to disease by applying state-of-the-art genome-wide approaches.
Abstract
Non-protein-coding transcripts have been conserved throughout evolution, indicating that crucial functions exist for these RNAs. For example, microRNAs (miRNAs) have been found to modulate most cellular processes. The protein classes of RNA-binding proteins include essential regulators of miRNA biogenesis, turnover and activity. RNA–RNA and protein–RNA interactions are essential for post-transcriptional regulation in normal development and may be deregulated in disease. In reviewing emerging concepts of the interplay between miRNAs and RNA-binding proteins, we highlight the implications of these complex layers of regulation in cancer initiation and progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009).
Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92–105 (2009).
Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834–838 (2005). The results presented in this paper had a big impact. It was found that miRNA expression profiles could be used to discriminate between normal and tumour tissue and, in addition, they reflected the developmental origin and differentiation state of the tumour. This led to discussion of the possible application of this finding in diagnosis and raised queries about the cause of global miRNA deregulation in tumours.
Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103, 2257–2261 (2006). Based on a panel of 540 solid tumour samples, an miRNA expression signature was presented that contains miRNAs that are differentially expressed in tumours. Many of their predicted targets were tumour suppressors or oncogenes, turning the miRNA genes into novel cancer genes.
Lunde, B. M., Moore, C. & Varani, G. RNA-binding proteins: modular design for efficient function. Nature Rev. Mol. Cell Biol. 8, 479–490 (2007).
Lukong, K. E., Chang, K. W., Khandjian, E. W. & Richard, S. RNA-binding proteins in human genetic disease. Trends Genet. 24, 416–425 (2008).
Riggi, N., Cironi, L., Suvà, M. L. & Stamenkovic, I. Sarcomas: genetics, signalling, and cellular origins. Part 1: the fellowship of TET. J. Pathol. 213, 4–20 (2007).
Rajan, P. et al. Regulation of gene expression by the RNA-binding protein Sam68 in cancer. Biochem. Soc. Trans. 36, 505–507 (2008).
Lee, H. K. et al. β-catenin regulates multiple steps of RNA metabolism as revealed by the RNA aptamer in colon cancer cells. Cancer Res. 67, 9315–9321 (2007).
David, C. J. & Manley, J. L. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24, 2343–2364 (2010).
Denli, A. M., Tops, B. B., Plasterk, R. H., Ketting, R. F. & Hannon, G. J. Processing of primary microRNAs by the Microprocessor complex. Nature 432, 231–235 (2004).
Gregory, R. I. The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235–240 (2004).
Yi, R., Qin, Y., Macara, I. G. & Cullen, B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011–3016 (2003).
Lund, E., Güttinger, S., Calado, A., Dahlberg, J. E. & Kutay, U. Nuclear export of microRNA precursors. Science 303, 95–98 (2004).
Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363–366 (2001).
Grishok, A. et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106, 23–34 (2001).
Hutvágner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834–838 (2001).
Chendrimada, T. P. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740–744 (2005).
Zhang, H., Kolb, F. A., Jaskiewicz, L., Westhof, E. & Filipowicz, W. Single processing center models for human Dicer and bacterial RNase III. Cell 118, 57–68 (2004).
MacRae, I. J., Zhou, K. & Doudna, J. A. Structural determinants of RNA recognition and cleavage by Dicer. Nature Struct. Mol. Biol. 14, 934–940 (2007).
Haase, A. D. et al. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 6, 961–967 (2005).
Chakravarthy, S., Sternberg, S. H., Kellenberger, C. A. & Doudna, J. A. Substrate-specific kinetics of dicer-catalyzed RNA processing. J. Mol. Biol. 404, 392–402 (2010).
Lee, Y. et al. The role of PACT in the RNA silencing pathway. EMBO J. 25, 522–532 (2006).
Meister, G. et al. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15, 185–197 (2004).
Cerutti, L., Mian, N. & Bateman, A. Domains in gene silencing and cell differentiation proteins: the novel PAZ domain and redefinition of the Piwi domain. Trends Biochem. Sci. 25, 481–482 (2000).
Song, J. J., Smith, S. K., Hannon, G. J. & Joshua-Tor, L. Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305, 1434–1437 (2004).
Ma, J. B., Ye, K. & Patel, D. J. Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain. Nature 429, 318–322 (2004).
Diederichs, S. & Haber, D. A. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131, 1097–1108 (2007).
Cheloufi, S., Dos Santos, C. O., Chong, M. M. & Hannon, G. J. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 465, 584–589 (2010).
Cifuentes, D. et al. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 328, 1694–1698 (2010).
Ambros, V. et al. A uniform system for microRNA annotation. RNA 9, 277–279 (2003).
Hutvágner, G. Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation. FEBS Lett. 579, 5850–5857 (2005).
Thomson, J. M. et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20, 2202–2207 (2006).
Zhang, L. et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA 103, 9136–9141 (2006).
Kim, M. S. et al. Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J. Pathol. 221, 139–146 (2010).
Lee, E. J. et al. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 14, 35–42 (2008).
Melo, S. A. et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18, 303–315 (2010).
Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R. & Jacks, T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nature Genet. 39, 673–677 (2007). This report provided evidence that impairment of miRNA biogenesis contributes to oncogenic transformation and is not merely a result of it. Independent knockdown of miRNA pathway components caused a global loss of miRNA (as observed in reference 3) and promoted tumour formation.
Lambertz, I. et al. Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo. Cell Death Differ. 17, 633–641 (2010).
Hill, D. A. et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 325, 965 (2009).
Kumar, M. S. et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 23, 2700–2704 (2009).
Martello, G. et al. A microRNA targeting Dicer for metastasis control. Cell 141, 1195–1207 (2010).
Melo, S. A. et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nature Genet. 41, 365–370 (2009).
Garre, P., Pérez-Segura, P., Díaz-Rubio, E., Caldés, T. & de la Hoya, M. Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer. Nature Genet. 42, 817–818 (2010).
Paroo, Z., Ye, X., Chen, S. & Liu, Q. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 139, 112–122 (2009).
Han, J. Posttranscriptional crossregulation between Drosha and DGCR8. Cell 136, 75–84 (2009).
Obernosterer, G., Leuschner, P. J., Alenius, M. & Martinez, J. Post-transcriptional regulation of microRNA expression. RNA 12, 1161–1167 (2006).
Fuller-Pace, F. V. & Moore, H. C. RNA helicases p68 and p72: multifunctional proteins with important implications for cancer development. Future Oncol. 7, 239–251 (2011).
Fukuda, T. et al. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nature Cell Biol. 9, 604–611 (2007).
Suzuki, H. I. et al. Modulation of microRNA processing by p53. Nature 460, 529–533 (2009).
Feng, Z., Zhang, C., Wu, R. & Hu, W. Tumor suppressor p53 meets microRNAs. J. Mol. Cell Biol. 3, 44–50 (2011).
Yamagata, K. Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol. Cell 36, 340–347 (2009).
Davis, B. N., Hilyard, A. C., Lagna, G. & Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56–61 (2008).
Davis, B. N., Hilyard, A. C., Nguyen, P. H., Lagna, G. & Hata, A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell 39, 373–384 (2010).
Yu, B. The FHA domain proteins DAWDLE in Arabidopsis and SNIP1 in humans act in small RNA biogenesis. Proc. Natl Acad. Sci. USA 105, 10073–10078 (2008).
Wendt, M. K., Allington, T. M. & Schiemann, W. P. Mechanisms of the epithelial-mesenchymal transition by TGF-β. Future Oncol. 5, 1145–1168 (2009).
Wu, H. A splicing-independent function of SF2/ASF in microRNA processing. Mol. Cell 38, 67–77 (2010).
Karni, R. et al. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nature Struct. Mol. Biol. 14, 185–193 (2007).
le Sage, C. et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 26, 3699–3708 (2007).
Nakamura, T., Canaani, E. & Croce, C. M. Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. Proc. Natl Acad. Sci. USA 104, 10980–10985 (2007).
Rybak, A. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nature Cell Biol. 10, 987–993 (2008).
Viswanathan, S. R. & Daley, G. Q. Lin28: a microRNA regulator with a macro role. Cell 140, 445–449 (2010).
Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L. & Struhl, K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell 39, 493–506 (2010).
Trabucchi, M. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459, 1010–1014 (2009).
Michlewski, G. & Cáceres, J. F. Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nature Struct. Mol. Biol. 17, 1011–1018 (2010).
Guil, S. & Cáceres, J. F. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nature Struct. Mol. Biol. 14, 591–596 (2007).
Michlewski, G., Guil, S., Semple, C. A. & Caceres, J. F. Posttranscriptional regulation of miRNAs harboring conserved terminal loops. Mol. Cell 32, 383–393 (2008).
Zhang, X. & Zeng, Y. The terminal loop region controls microRNA processing by Drosha and Dicer. Nucleic Acids Res. 38, 7689–7697 (2010).
Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Rev. Genet. 9, 102–114 (2008).
Eulalio, A., Huntzinger, E. & Izaurralde, E. Getting to the root of miRNA-mediated gene silencing. Cell 132, 9–14 (2008).
Hutvágner, G. & Zamore, P. D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 297, 2056–2060 (2002).
Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R. & Tuschl, T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563–574 (2002).
Höck, J. et al. Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. EMBO Rep. 8, 1052–1060 (2007).
Carmell, M. A., Xuan, Z., Zhang, M. Q. & Hannon, G. J. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev. 16, 2733–2742 (2002).
Azuma-Mukai, A. Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc. Natl Acad. Sci. USA 105, 7964–7969 (2008).
Su, H., Trombly, M. I., Chen, J. & Wang, X. Essential and overlapping functions for mammalian Argonautes in microRNA silencing. Genes Dev. 23, 304–317 (2009).
Eulalio, A., Tritschler, F. & Izaurralde, E. The GW182 protein family in animal cells: new insights into domains required for miRNA-mediated gene silencing. RNA 15, 1433–1442 (2009).
Huntzinger, E. & Izaurralde, E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nature Rev. Genet. 12, 99–110 (2011).
Djuranovic, S., Nahvi, A. & Green, R. A parsimonious model for gene regulation by miRNAs. Science 331, 550–553 (2011).
Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64–71 (2008).
Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–840 (2010).
Chu, C. Y. & Rana, T. M. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol. 4, e210 (2006).
Eulalio, A. et al. Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing. Genes Dev. 21, 2558–2570 (2007).
Lin, F. et al. Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo. Cancer Biol. Ther. 7, 1669–1676 (2008).
Salzman, D. W., Shubert-Coleman, J. & Furneaux, H. P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression. J. Biol. Chem. 282, 32773–32779 (2007).
Meister, G. et al. Identification of novel argonaute-associated proteins. Curr. Biol. 15, 2149–2155 (2005).
Chendrimada, T. P. et al. MicroRNA silencing through RISC recruitment of eIF6. Nature 447, 823–828 (2007).
Mourelatos, Z. et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16, 720–728 (2002).
Eulalio, A., Behm-Ansmant, I., Schweizer, D. & Izaurralde, E. P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol. Cell. Biol. 27, 3970–3981 (2007).
Landthaler, M. et al. Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA 14, 2580–2596 (2008).
Pare, J. M. Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies. Mol. Biol. Cell 20, 3273–3284 (2009).
Suzuki, Y. et al. The Hsp90 inhibitor geldanamycin abrogates colocalization of eIF4E and eIF4E-transporter into stress granules and association of eIF4E with eIF4G. J. Biol. Chem. 284, 35597–35604 (2009).
Iwasaki, S. et al. Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes. Mol. Cell 39, 292–299 (2010).
Andrei, M. A. et al. A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA 11, 717–727 (2005).
Johnston, M., Geoffroy, M. C., Sobala, A., Hay, R. & Hutvágner, G. HSP90 protein stabilizes unloaded argonaute complexes and microscopic P-bodies in human cells. Mol. Biol. Cell 21, 1462–1469 (2010).
Rybak, A. The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2. Nature Cell Biol. 11, 1411–1420 (2009).
Schwamborn, J. C., Berezikov, E. & Knoblich, J. A. The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 136, 913–925 (2009).
Neumuller, R. A. Mei-P26 regulates microRNAs and cell growth in the Drosophila ovarian stem cell lineage. Nature 454, 241–245 (2008).
Kano, S., Miyajima, N., Fukuda, S. & Hatakeyama, S. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2. Cancer Res. 68, 5572–5580 (2008).
Weinmann, L. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell 136, 496–507 (2009).
Parker, R. & Song, H. The enzymes and control of eukaryotic mRNA turnover. Nature Struct. Mol. Biol. 11, 121–127 (2004).
Zhang, K. et al. The human homolog of yeast SEP1 is a novel candidate tumor suppressor gene in osteogenic sarcoma. Gene 298, 121–127 (2002).
Hinman, M. N. & Lou, H. Diverse molecular functions of Hu proteins. Cell. Mol. Life Sci. 65, 3168–3181 (2008).
Bhattacharyya, S. N., Habermacher, R., Martine, U., Closs, E. I. & Filipowicz, W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125, 1111–1124 (2006). In this paper, the first example of stress-induced relief of miRNA-mediated repression through binding of an RBP to the 3′ UTR was described.
Wang, W. et al. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 20, 760–769 (2000).
Kullmann, M., Göpfert, U., Siewe, B. & Hengst, L. ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes Dev. 16, 3087–3099 (2002).
Leandersson, K., Riesbeck, K. & Andersson, T. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res. 34, 3988–3999 (2006).
Saunus, J. M. et al. Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR. Cancer Res. 68, 9469–9478 (2008).
Kim, H. H. et al. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev. 23, 1743–1748 (2009). In contrast to the stabilizing function of HuR described in reference 104, this RBP was found to be required for let-7-mediated target repression.
Abdelmohsen, K. & Gorospe, M. Posttranscriptional regulation of cancer traits by HuR. RNA 1, 214–229 (2010).
Abdelmohsen, K., Srikantan, S., Kuwano, Y. & Gorospe, M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc. Natl Acad. Sci. USA 105, 20297–20302 (2008).
Guo, X., Wu, Y. & Hartley, R. S. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol. 6, 575–583 (2009).
Abdelmohsen, K. et al. miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 9, 1354–1359 (2010).
Pullmann, R. et al. Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs. Mol. Cell. Biol. 27, 6265–6278 (2007).
Topisirovic, I. et al. Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer. Mol. Cell. Biol. 29, 1152–1162 (2009). This paper reports that HuR and eIF4E cooperatively stabilize mRNA targets, while eIF4E mRNA is stabilized by HuR. Such regulative loops add a layer of complexity onto the interplay of RBPs.
Wendel, H. G. et al. Dissecting eIF4E action in tumorigenesis. Genes Dev. 21, 3232–3237 (2007).
Furic, L. et al. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc. Natl Acad. Sci. USA 107, 14134–14139 (2010).
Mili, S., Shu, H. J., Zhao, Y. & Piñol-Roma, S. Distinct RNP complexes of shuttling hnRNP proteins with pre-mRNA and mRNA: candidate intermediates in formation and export of mRNA. Mol. Cell. Biol. 21, 7307–7319 (2001).
Lal, A. et al. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 23, 3092–3102 (2004).
Chen, C. Y. et al. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107, 451–464 (2001).
Fialcowitz, E. J., Brewer, B. Y., Keenan, B. P. & Wilson, G. M. A hairpin-like structure within an AU-rich mRNA-destabilizing element regulates trans-factor binding selectivity and mRNA decay kinetics. J. Biol. Chem. 280, 22406–22417 (2005).
Wilson, G. M., Sutphen, K., Chuang, K. & Brewer, G. Folding of A+U-rich RNA elements modulates AUF1 binding. Potential roles in regulation of mRNA turnover. J. Biol. Chem. 276, 8695–8704 (2001).
Wilson, G. M., Sutphen, K., Moutafis, M., Sinha, S. & Brewer, G. Structural remodeling of an A + U-rich RNA element by cation or AUF1 binding. J. Biol. Chem. 276, 38400–38409 (2001).
Shih, S. C. & Claffey, K. P. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J. Biol. Chem. 274, 1359–1365 (1999).
Jafarifar, F., Yao, P., Eswarappa, S. M. & Fox, P. L. Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J. 30, 1324–1334 (2011). The binding of HNRNPL to the VEGFA 3′ UTR competes with miRNA binding and changes the RNA conformation.
Ray, P. S. et al. A stress-responsive RNA switch regulates VEGFA expression. Nature 457, 915–919 (2009). Under hypoxic conditions, the binding of HNRNPL to the VEGFA 3′ UTR changes the RNA secondary structure and relieves IFNγ-induced repression of VEFGA by GAIT, showing how the response to combined stimuli is orchestrated. Together with reference 125, these data demonstrate how HNRNPL can relieve two repressive mechanisms simultaneously.
Goldberg-Cohen, I., Furneauxb, H. & Levy, A. P. A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J. Biol. Chem. 277, 13635–13640 (2002).
Eiring, A. M. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 140, 652–665 (2010). This paper uniquely describes a decoy function of an miRNA. miR-328 competes with CEPBA mRNA for binding of HNRNPE2. CEPBA is a transcriptional activator of the miR-328 gene, thus forming a positive feedback loop.
Chang, J. S. et al. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPα-driven myeloid differentiation. Blood 110, 994–1003 (2007).
Fazi, F. et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 123, 819–831 (2005).
Evans, J. R. et al. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22, 8012–8020 (2003).
Fenger-Grøn, M., Fillman, C., Norrild, B. & Lykke-Andersen, J. Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol. Cell 20, 905–915 (2005).
Carballo, E., Lai, W. S. & Blackshear, P. J. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281, 1001–1005 (1998).
Sawaoka, H., Dixon, D. A., Oates, J. A. & Boutaud, O. Tristetraprolin binds to the 3′-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site. J. Biol. Chem. 278, 13928–13935 (2003).
Lai, W. S., Parker, J. S., Grissom, S. F., Stumpo, D. J. & Blackshear, P. J. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol. Cell. Biol. 26, 9196–9208 (2006).
Marderosian, M. et al. Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene 25, 6277–6290 (2006).
Lee, H. H. et al. Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin. J. Biol. Chem. 285, 17329–17337 (2010).
Stoecklin, G. et al. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 283, 11689–11699 (2008).
Brennan, S. E. et al. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res. 69, 5168–5176 (2009).
von Roretz, C. & Gallouzi, I. E. Decoding ARE-mediated decay: is microRNA part of the equation? J. Cell Biol. 181, 189–194 (2008).
Jing, Q. et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120, 623–634 (2005). These data indicate that the RBP TTP, an mRNA decay factor that binds AREs and generally operates by uncapping, assists miR-16 in targeting AREs by interacting with AGO2 or other RISC factors, showing the versatility of RBPs.
Noubissi, F. K. et al. CRD-BP mediates stabilization of βTrCP1 and c-myc mRNA in response to β-catenin signalling. Nature 441, 898–901 (2006).
Hafner, M. et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129–141 (2010).
Weidensdorfer, D. et al. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA 15, 104–115 (2009).
Elcheva, I., Goswami, S., Noubissi, F. K. & Spiegelman, V. S. CRD-BP protects the coding region of βTrCP1 mRNA from miR-183-mediated degradation. Mol. Cell 35, 240–246 (2009). This paper shows that the RBP IFG2BP1 can bind a coding region in a specific target and can alleviate the interaction between miR-183 in complex with RISC and its target site, which is also located in the coding region.
Goswami, S. et al. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. J. Biol. Chem 285, 20532–20540 (2010). The RBP IGF2BP1 can also antagonize miRNA-mediated repression through the 3′ UTR, illustrating the multifunctional character of this protein.
Köbel, M. et al. Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma. Oncogene 26, 7584–7589 (2007).
Galgano, A. et al. Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system. PLoS ONE 3, e3164 (2008).
Kedde, M. et al. A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility. Nature Cell Biol. 12, 1014–1020 (2010). This is the first report of a reverse complementary RBP recognition site and miRNA site that form a stem–loop structure in the absence of the RBP PUM1. This emphasizes the importance of RNA secondary structure for miRNA accessibility.
Morris, A. R., Mukherjee, N. & Keene, J. D. Ribonomic analysis of human Pum1 reveals cis-trans conservation across species despite evolution of diverse mRNA target sets. Mol. Cell. Biol. 28, 4093–4103 (2008).
Leibovich, L., Mandel-Gutfreund, Y. & Yakhini, Z. A structural-based statistical approach suggests a cooperative activity of PUM1 and miR-410 in human 3′-untranslated regions. Silence 1, 17 (2010).
Vasudevan, S. & Steitz, J. A. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 128, 1105–1118 (2007).
Vasudevan, S., Tong, Y. & Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931–1934 (2007).
Garnon, J. et al. Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level. J. Biol. Chem. 280, 5750–5763 (2005).
Zhang, H., Lee, J. Y. & Tian, B. Biased alternative polyadenylation in human tissues. Genome Biol. 6, R100 (2005).
Sandberg, R., Neilson, J. R., Sarma, A., Sharp, P. A. & Burge, C. B. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320, 1643–1647 (2008). This paper shows that shorter 3′ UTRs, as expressed in proliferating and undifferentiated cells, confer post-transcriptional mRNA stability and higher protein levels. This implies that the function of the 3′ UTR is mainly repressive and that regulation by repressors acting on the 3′ UTR seems to be essential for maintaining correct gene expression.
Legendre, M., Ritchie, W., Lopez, F. & Gautheret, D. Differential repression of alternative transcripts: a screen for miRNA targets. PLoS Comput. Biol. 2, e43 (2006).
Mayr, C. & Bartel, D. P. Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673–684 (2009). In this paper, the consequences of alternative PAS usage for oncogenic transformation are shown by isoforms of IGF2BP1, in agreement with the data presented in reference 156.
Licatalosi, D. D. & Darnell, R. B. RNA processing and its regulation: global insights into biological networks. Nature Rev. Genet. 11, 75–87 (2010).
Kertesz, M. et al. Genome-wide measurement of RNA secondary structure in yeast. Nature 467, 103–107 (2010).
Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A. & Enright, A. J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140–D144 (2006).
Berezikov, E., Cuppen, E. & Plasterk, R. H. Approaches to microRNA discovery. Nature Genet. 38, S2–S7 (2006).
Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401–1414 (2007).
Forman, J. J. & Coller, H. A. The code within the code: microRNAs target coding regions. Cell Cycle 9, 1533–1541 (2010).
Stefani, G. & Slack, F. J. Small non-coding RNAs in animal development. Nature Rev. Mol. Cell Biol. 9, 219–230 (2008).
Farh, K. K. et al. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 310, 1817–1821 (2005).
Kloosterman, W. P. & Plasterk, R. H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441–450 (2006).
Lima, R. T. et al. MicroRNA regulation of core apoptosis pathways in cancer. Eur. J. Cancer 47, 163–174 (2011).
Negrini, M., Nicoloso, M. S. & Calin, G. A. MicroRNAs and cancer — new paradigms in molecular oncology. Curr. Opin. Cell Biol. 21, 470–479 (2009).
Urbich, C., Kuehbacher, A. & Dimmeler, S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 79, 581–588 (2008).
Gregory, P. A., Bracken, C. P., Bert, A. G. & Goodall, G. J. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7, 3112–3118 (2008).
Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. & Calin, G. A. MicroRNAs — the micro steering wheel of tumour metastases. Nature Rev. Cancer 9, 293–302 (2009).
Olson, P. et al. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 23, 2152–2165 (2009).
Volinia, S. et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 20, 589–599 (2010).
Voorhoeve, P. M. MicroRNAs: oncogenes, tumor suppressors or master regulators of cancer heterogeneity? Biochim. Biophys. Acta 1805, 72–86 (2010).
Farazi, T. A., Spitzer, J. I., Morozov, P. & Tuschl, T. miRNAs in human cancer. J. Pathol. 223, 102–115 (2011).
Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nature Rev. Cancer 6, 857–866 (2006).
Ventura, A. & Jacks, T. MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586–591 (2009).
Ryan, B. M., Robles, A. I. & Harris, C. C. Genetic variation in microRNA networks: the implications for cancer research. Nature Rev. Cancer 10, 389–402 (2010).
Kim, V. N., Han, J. & Siomi, M. C. Biogenesis of small RNAs in animals. Nature Rev. Mol. Cell Biol. 10, 126–139 (2009).
Krol, J., Loedige, I. & Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nature Rev. Genet. 11, 597–610 (2010).
Kedde, M. et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131, 1273–1286 (2007). This paper describes an RBP, which interacts with the 3′ UTR of some germ cell genes and allows their expression by preventing miRNA-mediated repression during germ cell development in zebrafish.
Voorhoeve, P. M. et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169–1181 (2006).
Huang, Q. et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature Cell Biol. 10, 202–210 (2008).
Bhattacharya, C., Aggarwal, S., Kumar, M., Ali, A. & Matin, A. Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1). PLoS ONE 3, e2315 (2008).
Takeda, Y., Mishima, Y., Fujiwara, T., Sakamoto, H. & Inoue, K. DAZL relieves miRNA-mediated repression of germline mRNAs by controlling poly(A) tail length in zebrafish. PLoS ONE 4, e7513 (2009). This paper states that miRNA-mediated repression can be counteracted through poly(A)-tail elongation controlled by an RBP during germ cell development in zebrafish.
Moore, F. L. et al. Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins. Proc. Natl Acad. Sci. USA 100, 538–543 (2003).
Fox, M., Urano, J. & Reijo Pera, R. A. Identification and characterization of RNA sequences to which human PUMILIO-2 (PUM2) and deleted in Azoospermia-like (DAZL) bind. Genomics 85, 92–105 (2005).
Fabian, M. R., Sonenberg, N. & Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351–379 (2010).
Tritschler, F., Huntzinger, E. & Izaurralde, E. Role of GW182 proteins and PABPC1 in the miRNA pathway: a sense of déjà vu. Nature Rev. Mol. Cell Biol. 11, 379–384 (2010).
Tenenbaum, S. A., Carson, C. C., Lager, P. J. & Keene, J. D. Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc. Natl Acad. Sci. USA 97, 14085–14090 (2000).
Galarneau, A. & Richard, S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nature Struct. Mol. Biol. 12, 691–698 (2005).
Lorenz, C., von Pelchrzim, F. & Schroeder, R. Genomic systematic evolution of ligands by exponential enrichment (Genomic SELEX) for the identification of protein-binding RNAs independent of their expression levels. Nature Protoc. 1, 2204–2212 (2006).
Licatalosi, D. D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464–469 (2008).
Beach, D. L. & Keene, J. D. Ribotrap: targeted purification of RNA-specific RNPs from cell lysates through immunoaffinity precipitation to identify regulatory proteins and RNAs. Methods Mol. Biol. 419, 69–91 (2008).
Ray, D. et al. Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins. Nature Biotech. 27, 667–670 (2009).
Slobodin, B. & Gerst, J. E. A novel mRNA affinity purification technique for the identification of interacting proteins and transcripts in ribonucleoprotein complexes. RNA 16, 2277–2290 (2010).
Acknowledgements
We thank A. Morris for critical reading of the manuscript and the members of the R.A. group for their suggestions. This work was supported by the EURYI (European Research Young Investigator Award), ERC (European Research Council), KWF (Koningin Wilhelmina Fonds; Dutch Cancer Foundation) and Horizon-NWO (Nederlandse Organizatie voor Wetenschappelijk Onderzoek; R.A.). We apologize to colleagues whose work was not cited because of space limitations.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Glossary
- Passenger strand
-
The strand of the microRNA duplex that is complementary to the guide strand and is destined for degradation upon loading of the guide strand into the microRNA-induced silencing complex (miRISC).
- Seed
-
Six to eight nucleotides at the 5′ end of the mature microRNA that are involved in the recognition of target mRNAs.
- P-bodies
-
Cytoplasmic foci containing proteins involved in diverse post-transcriptional processes, such as mRNA degradation.
- AU-rich element
-
(ARE). An element that is present in certain 3′ untranslated regions. It often contains a repeat of the AUUUA motif, which has a destabilizing effect on the mRNA in which it resides.
Rights and permissions
About this article
Cite this article
van Kouwenhove, M., Kedde, M. & Agami, R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 11, 644–656 (2011). https://doi.org/10.1038/nrc3107
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc3107
This article is cited by
-
The multifaceted role of Fragile X-Related Protein 1 (FXR1) in cellular processes: an updated review on cancer and clinical applications
Cell Death & Disease (2024)
-
VGLL3 is a mechanosensitive protein that promotes cardiac fibrosis through liquid–liquid phase separation
Nature Communications (2023)
-
An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus
Nature Cell Biology (2023)
-
The Detection of Urinary Exosomal miRNAs for Cancer Diagnostics and Prognostics
BioChip Journal (2023)
-
The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4
Breast Cancer Research and Treatment (2023)